First-Line Anti-Egfr Agents (Panitumumab or Cetuximab) Plus Chemotherapy in Patients With Metastatic Colorectal Cancer: Onco-Colon Turkey Study Subgroup Analysis

No Thumbnail Available

Date

2022

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

Description

Keywords

Turkish CoHE Thesis Center URL

WoS Q

Q1

Scopus Q

Q1

Source

ESMO 24th World Congress on Gastrointestinal Cancer -- JUN 29-JUL 02, 2022 -- Barcelona, SPAIN

Volume

33

Issue

Start Page

S281

End Page

S281
Google Scholar Logo
Google Scholar™